These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25408727)

  • 21. Urothelial Carcinoma With Squamous Differentiation Is Associated With High Tumor Stage and Pelvic Lymph-Node Metastasis.
    Liu Y; Bui MM; Xu B
    Cancer Control; 2017 Jan; 24(1):78-82. PubMed ID: 28178718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of histological reclassification during pathology re-review--evidence of a Will Rogers effect in bladder cancer?
    Linder BJ; Boorjian SA; Cheville JC; Sukov WR; Thapa P; Tarrell RF; Frank I
    J Urol; 2013 Nov; 190(5):1692-6. PubMed ID: 23707452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis.
    Koga F; Yoshida S; Kawakami S; Kageyama Y; Yokoyama M; Saito K; Fujii Y; Kobayashi T; Kihara K
    Urology; 2008 Aug; 72(2):384-8. PubMed ID: 18455771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases.
    Lagwinski N; Thomas A; Stephenson AJ; Campbell S; Hoschar AP; El-Gabry E; Dreicer R; Hansel DE
    Am J Surg Pathol; 2007 Dec; 31(12):1777-87. PubMed ID: 18043032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis.
    Linder BJ; Frank I; Cheville JC; Thompson RH; Thapa P; Tarrell RF; Boorjian SA
    J Urol; 2013 May; 189(5):1670-5. PubMed ID: 23142686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome.
    Holmäng S; Lele SM; Johansson SL
    J Urol; 2007 Jul; 178(1):51-6. PubMed ID: 17574059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of the Memorial Sloan Kettering Cancer Center nomogram in the prognosis of patients treated with radical cystectomy for invasive bladder cancer.
    Molina Escudero R; Herranz Amo F; Monzo Gardiner J; Paez Borda A; Hernandez Fernandez C
    Arch Esp Urol; 2013 Nov; 66(9):859-64. PubMed ID: 24231296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bladder cancer and urothelial tumors. New therapeutic strategies].
    Desgrandchamps F; Hennequin C; Culine S
    Rev Prat; 2014 Dec; 64(10):1363-4. PubMed ID: 25665313
    [No Abstract]   [Full Text] [Related]  

  • 32. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.
    Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L
    Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma.
    Smaldone MC; Jacobs BL; Smaldone AM; Hrebinko RL
    Urology; 2008 Sep; 72(3):613-6. PubMed ID: 18554696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience.
    Choong NW; Quevedo JF; Kaur JS
    Cancer; 2005 Mar; 103(6):1172-8. PubMed ID: 15700264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases.
    Fritsche HM; Burger M; Denzinger S; Legal W; Goebell PJ; Hartmann A
    J Urol; 2008 Nov; 180(5):1923-7. PubMed ID: 18801525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients.
    Hautmann RE; de Petriconi RC; Pfeiffer C; Volkmer BG
    Eur Urol; 2012 May; 61(5):1039-47. PubMed ID: 22381169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of Histological Variant on Oncological Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.
    Takemoto K; Teishima J; Kohada Y; Ikeda K; Nagamatsu H; Goriki A; Inoue S; Hayashi T; Kajiwara M; Matsubara A
    Anticancer Res; 2020 Aug; 40(8):4787-4793. PubMed ID: 32727806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncologic outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cystectomy: with mean follow-up of 3.5 years.
    Mmeje CO; Nunez-Nateras R; Nielsen ME; Pruthi RS; Smith A; Wallen EM; Humphreys MR; Woods ME; Castle EP
    Urol Oncol; 2013 Nov; 31(8):1621-7. PubMed ID: 22534088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.